Intra-Cellular Therapies, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -20.77 | -100% |
| P/S |
|
14.59 | 33.58 | -56.54% |
|
|
| P/BV |
|
11.41 | 4.79 | 137.99% |
|
|
| P/FCF |
|
-43.38 | 60.06 | -172.24% |
|
|
| Ev/Ebitda |
|
-41.64 | -17.26 | 141.24% |
|
|
| Ev/S |
|
14.31 | 22.49 | -36.35% |
|
|
| Ev/FCF |
|
-53.14 | 67.63 | -178.58% |
|
|
| E/P |
|
-0.0259 | 0.0168 | -253.78% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-34.37 | 4.5 | -864.4% | -51121.23 | -99.93% |
| ROE |
|
-23.62 | 9.39 | -351.47% |
|
|
| ROA |
|
-19.18 | 0.1519 | -12723.52% |
|
|
| ROIC |
|
-41.78 | 7.63 | -647.26% |
|
|
| ROS |
|
-30.22 | -25.64 | 17.86% |
|
|
| ROCE |
|
-26.95 | 15.19 | -277.46% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1066 | -3.68 | -97.1% | -0.097 | +9.88% |
| Nеt Debt/Ebitda |
|
0.8236 | -4.07 | -120.25% |
|
|
| Debt/Ratio |
|
0.0233 | 0.199 | -88.31% |
|
|
| Debt/Equity |
|
8.91 | 1.67 | 435.39% |
|
|
| Debt/Net Income |
|
-0.1213 | 10.34 | -101.17% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
761162.3 | 76.2 | 998800.66% | ||
| Growth impulse Ebitda in 5 years |
|
3.15 | 44.75 | -92.96% | ||
| Growth impulse Net Income in 5 years |
|
-5.43 | -15.36 | -64.65% | ||
| Growth impulse FCF in 5 years |
|
-3.29 | -9.39 | -64.96% | ||
| Growth impulse EPS in 5 years |
|
-45.64 | -84.03 | -45.69% |
IP Score
2.38/10
